Product managers in regulated industries do a job that looks similar to other PMs but plays by stricter rules. A misread requirement in a consumer app costs you a sprint. A misread requirement in a healthcare app can cost you a patient, a fine, or a recall. Interviewers know these stakes. The questions check how you operate when speed, safety, and law all sit at the same table.
This post breaks down what to study for healthcare and regulated interviews. It draws on guidance from Marty Cagan, Teresa Torres, and Jeff Gothelf. The goal is a clear study plan, not a list of acronyms.
Why these interviews feel different
Most PM loops focus on user value, feasibility, and business viability. In regulated industries, you add a fourth lens: legal and clinical risk. You will hear questions like "How would you handle a near miss in a clinical workflow?" or "Walk me through a launch under FDA review." These are not trick questions. They test whether you can ship value without breaking trust or breaking laws.
Marty Cagan calls product discovery a way to "address the risks before you write code" (Cagan 23). In a regulated context, those risks include regulatory risk and ethical risk, on top of usability and value. A strong answer maps all four early, well before an audit can find them.
Study area 1: HIPAA and patient privacy
HIPAA covers protected health information in the United States. As a PM, you do not need to recite the statute. You need to know what triggers it and how it shapes design decisions.
Three rules drive most product choices: the Privacy Rule, the Security Rule, and the Breach Notification Rule. The Privacy Rule limits how you can use patient data. The Security Rule sets the technical and administrative safeguards. The Breach Notification Rule defines what counts as a breach and how fast you must file a report.
In an interview, you may face a prompt like "Design a messaging feature for a hospital app." A weak answer jumps to UX. A strong answer asks first: who are the senders, who are the receivers, what data flows through, and where does it sit at rest? You then walk through encryption at rest, access controls, audit logs, and user consent. Teresa Torres notes that good discovery uncovers "assumptions that, if wrong, would cause the idea to fail" (Torres 56). With HIPAA, those assumptions sit in the legal column, not the user column.
Study area 2: FDA pathways and SaMD
If your product makes a medical claim or supports a clinical decision, the FDA may treat it as Software as a Medical Device, or SaMD. The path you take shapes scope, timeline, and cost.
Four pathways come up most often: 510(k), De Novo, Premarket Approval, and exemption. The 510(k) lets you show your product is "substantially equivalent" to a legally marketed device. De Novo is for novel low to moderate risk products. Premarket Approval is the strictest path, used for high risk Class III devices. Exemption applies when a feature falls short of the SaMD bar.
A common interview move is to give you a product idea, then ask which path you would target and the reason for that choice. You should be ready to defend a choice based on intended use, risk class, and prior art. You should also flag the gaps in your knowledge. Honesty about the unknown is not a weakness in regulated PM work. It shows you understand the stakes.
Study area 3: Validation, not just testing
In consumer products, "shipping fast and learning" is a virtue. In regulated products, you still want to learn fast, but the test plan must be defensible to an auditor. That means design controls, traceability, and documented validation.
Jeff Gothelf and Josh Seiden argue that good outcomes come from "small experiments that test specific assumptions" (Gothelf and Seiden 41). That logic still holds in healthcare. The change is that experiments must be planned, recorded, and traceable to a requirement. You cannot A/B test a clinical recommendation engine the way you A/B test a checkout flow.
A strong answer splits work into two streams: discovery experiments that explore the unknown, and verification activities that prove the product meets a known requirement. This split helps you move quickly on early ideas while staying audit ready on shipped features.
Study area 4: Risk and the failure mode mindset
Regulated PMs use tools like FMEA, or Failure Mode and Effects Analysis. You do not need to run an FMEA in the interview. You do need to think in FMEA terms. For each feature, ask: what could go wrong, how bad would it be, and how would we spot the failure.
Lenny Rachitsky writes that the best PMs "obsess over both upside and downside scenarios" (Rachitsky). In regulated work, the downside scenarios include patient harm, audit findings, and class actions. Speak to those by name. Show you have a plan for each scenario.
A clean way to structure an answer is to list a top user value, the top failure mode that could block that value, and your first safeguard. Three sentences. No jargon.
What to practice before the loop
Pick one regulated domain as your target. Healthcare, fintech, and aerospace are common choices. For your domain, learn the top two or three regulations, the most common product types, and the standard pathways for launch. Read one whitepaper and one case study. That is enough to sound informed without faking depth.
Then run a mock interview with two prompts: a design question that hides a privacy or safety angle, and a metrics question that hides a regulatory reporting need. Record the session. Listen for moments where you skipped a risk to chase a feature. Those are the gaps to close before the loop.
Hold both ideas
Regulated industries reward PMs who hold two ideas at once: ship value, protect users. Study the rules, but treat them as a starting point. Study the tradeoffs. Study the failure modes. Then, in the room, lead with the user, name the risks, and show your mitigation plan.
Works Cited
Cagan, Marty. Inspired: How to Create Tech Products Customers Love. 2nd ed., Wiley, 2018.
Gothelf, Jeff, and Josh Seiden. Lean UX: Designing Great Products with Agile Teams. 3rd ed., O'Reilly Media, 2021.
Rachitsky, Lenny. "What Distinguishes the Top 1% of Product Managers." Lenny's Newsletter, 2023, www.lennysnewsletter.com.
Torres, Teresa. Continuous Discovery Habits: Discover Products that Create Customer Value and Business Value. Product Talk, 2021.